| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |
12,14-Prostaglandin J21
Biomedical Sciences Division and Biology Department, University of California, Riverside, California 92521-0121 [P. A. C., C-H. H., T. B., D. S. S.], and Department of Molecular, Cellular, and Developmental Biology, University of California, Santa Barbara, California 93106 [S. D., C. E. S.]
The D-group cyclins play a key role in the progression of cells through the G1 phase of the cell cycle. Treatment of MCF-7 breast cancer cells with the cyclopentenone prostaglandin 15-deoxy-
12,14-PGJ2 (15d-PGJ2) results in rapid down-regulation of cyclin D1 protein expression and growth arrest in the G0/G1 phase of the cell cycle. 15d-PGJ2 also down-regulates the expression of cyclin D1 mRNA; however, this effect is delayed relative to the effect on cyclin D1 protein levels, suggesting that the regulation of cyclin D1 occurs at least partly at the level of translation or protein turnover. Treatment of MCF-7 cells with 15d-PGJ2 leads to a rapid increase in the phosphorylation of protein synthesis initiation factor eukaryotic initiation factor 2
(eIF-2
) and a shift of cyclin D1 mRNA from the polysome-associated to free mRNA fraction, indicating that 15d-PGJ2 inhibits the initiation of cyclin D1 mRNA translation. The selective rapid decrease in cyclin D1 protein accumulation is facilitated by its rapid turnover (t1/2=34 min) after inhibition of cyclin D1 protein synthesis. The half-life of cyclin D1 protein is not significantly altered in cells treated with 15d-PGJ2. Treatment of cells with 15d-PGJ2 results in strong induction of heat shock protein 70 (HSP70) gene expression, suggesting that 15d-PGJ2 might activate protein kinase R (PKR), an eIF-2
kinase shown previously to be responsive to agents that induce stress. 15d-PGJ2 strongly stimulates eIF-2
phosphorylation and down-regulates cyclin D1 expression in a cell line derived from wild-type mouse embryo fibroblasts but has an attenuated effect in PKR-null cells, providing evidence that PKR is involved in mediating the effect of 15d-PGJ2 on eIF-2
phosphorylation and cyclin D1 expression. In summary, treatment of MCF-7 cells with 15d-PGJ2 results in increased phosphorylation of eIF-2
and inhibition of cyclin D1 mRNA translation initiation. At later time points, repression of cyclin D1 mRNA expression may also contribute to the decrease in cyclin D1 protein.
This article has been cited by other articles:
![]() |
S. I. Nikolaev, S. Deutsch, R. Genolet, C. Borel, L. Parand, C. Ucla, F. Schutz, G. Duriaux Sail, Y. Dupre, P. Jaquier-Gubler, et al. Transcriptional and post-transcriptional profile of human chromosome 21 Genome Res., August 1, 2009; 19(8): 1471 - 1479. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Tapia, M. Huerta, S. Islas, A. Avila-Flores, E. Lopez-Bayghen, J. Weiske, O. Huber, and L. Gonzalez-Mariscal Zona Occludens-2 Inhibits Cyclin D1 Expression and Cell Proliferation and Exhibits Changes in Localization along the Cell Cycle Mol. Biol. Cell, February 1, 2009; 20(3): 1102 - 1117. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Fernando, J. S. Foster, A. Bible, A. Strom, R. G. Pestell, M. Rao, A. Saxton, S. J. Baek, K. Yamaguchi, R. Donnell, et al. Breast Cancer Cell Proliferation Is Inhibited by BAD: REGULATION OF CYCLIN D1 J. Biol. Chem., September 28, 2007; 282(39): 28864 - 28873. [Abstract] [Full Text] [PDF] |
||||
![]() |
D. L. Williamson, D. R. Bolster, S. R. Kimball, and L. S. Jefferson Time course changes in signaling pathways and protein synthesis in C2C12 myotubes following AMPK activation by AICAR. Am J Physiol Endocrinol Metab, July 1, 2006; 291(1): E80 - E89. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. A. Hizli, A. R. Black, M. A. Pysz, and J. D. Black Protein Kinase C {alpha} Signaling Inhibits Cyclin D1 Translation in Intestinal Epithelial Cells J. Biol. Chem., May 26, 2006; 281(21): 14596 - 14603. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Konopleva, W. Zhang, Y.-X. Shi, T. McQueen, T. Tsao, M. Abdelrahim, M. F. Munsell, M. Johansen, D. Yu, T. Madden, et al. Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells. Mol. Cancer Ther., February 1, 2006; 5(2): 317 - 328. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Kassouf, S. Chintharlapalli, M. Abdelrahim, G. Nelkin, S. Safe, and A. M. Kamat Inhibition of Bladder Tumor Growth by 1,1-Bis(3'-Indolyl)-1-(p-Substitutedphenyl)Methanes: A New Class of Peroxisome Proliferator-Activated Receptor {gamma} Agonists Cancer Res., January 1, 2006; 66(1): 412 - 418. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Hong, I. Samudio, S. Liu, M. Abdelrahim, and S. Safe Peroxisome Proliferator-Activated Receptor {gamma}-Dependent Activation of p21 in Panc-28 Pancreatic Cancer Cells Involves Sp1 and Sp4 Proteins Endocrinology, December 1, 2004; 145(12): 5774 - 5785. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, S. Ringquist, A. H. Cho, G. Rondeau, and J. Welsh High-throughput polyribosome fractionation Nucleic Acids Res., June 1, 2004; 32(10): e79 - e79. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Qin, D. Morrow, J. Stewart, K. Spencer, W. Porter, R. Smith III, T. Phillips, M. Abdelrahim, I. Samudio, and S. Safe A new class of peroxisome proliferator-activated receptor {gamma} (PPAR{gamma}) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3'-indolyl)-1-(p-substituted phenyl)methanes Mol. Cancer Ther., March 1, 2004; 3(3): 247 - 260. [Abstract] [Full Text] |
||||
![]() |
S. M. Weber, A. L. Scarim, and J. A. Corbett PPAR{gamma} is not required for the inhibitory actions of PGJ2 on cytokine signaling in pancreatic {beta}-cells Am J Physiol Endocrinol Metab, March 1, 2004; 286(3): E329 - E336. [Abstract] [Full Text] |
||||
![]() |
C. J. Nelsen, D. G. Rickheim, M. M. Tucker, T. J. McKenzie, L. K. Hansen, R. G. Pestell, and J. H. Albrecht Amino Acids Regulate Hepatocyte Proliferation through Modulation of Cyclin D1 Expression J. Biol. Chem., July 3, 2003; 278(28): 25853 - 25858. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Cancer Research | Clinical Cancer Research |
| Cancer Epidemiology Biomarkers & Prevention | Molecular Cancer Therapeutics |
| Molecular Cancer Research | Cell Growth & Differentiation |